NVO跌了
发表于 ： 02 5月 2024, 08:35
Ozempic-maker Novo Nordisk () announced robust first-quarter results and hiked its financial outlook. However, shares of the Danish pharmaceutical major have come under pressure in the early trading session today as it faces supply constraints.